1. Home
  2. CNS vs TMDX Comparison

CNS vs TMDX Comparison

Compare CNS & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNS
  • TMDX
  • Stock Information
  • Founded
  • CNS 1986
  • TMDX 1998
  • Country
  • CNS United States
  • TMDX United States
  • Employees
  • CNS N/A
  • TMDX N/A
  • Industry
  • CNS Investment Managers
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CNS Finance
  • TMDX Health Care
  • Exchange
  • CNS Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • CNS 4.4B
  • TMDX 4.7B
  • IPO Year
  • CNS 2004
  • TMDX 2019
  • Fundamental
  • Price
  • CNS $94.21
  • TMDX $138.97
  • Analyst Decision
  • CNS Sell
  • TMDX Buy
  • Analyst Count
  • CNS 2
  • TMDX 11
  • Target Price
  • CNS $79.50
  • TMDX $158.82
  • AVG Volume (30 Days)
  • CNS 193.3K
  • TMDX 1.3M
  • Earning Date
  • CNS 10-16-2024
  • TMDX 11-04-2024
  • Dividend Yield
  • CNS 2.50%
  • TMDX N/A
  • EPS Growth
  • CNS N/A
  • TMDX N/A
  • EPS
  • CNS 2.55
  • TMDX 0.09
  • Revenue
  • CNS $487,356,000.00
  • TMDX $358,759,000.00
  • Revenue This Year
  • CNS $4.72
  • TMDX $87.59
  • Revenue Next Year
  • CNS $11.92
  • TMDX $31.51
  • P/E Ratio
  • CNS $36.23
  • TMDX $1,553.17
  • Revenue Growth
  • CNS N/A
  • TMDX 137.47
  • 52 Week Low
  • CNS $50.05
  • TMDX $36.42
  • 52 Week High
  • CNS $97.57
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • CNS 57.96
  • TMDX 39.43
  • Support Level
  • CNS $91.28
  • TMDX $141.40
  • Resistance Level
  • CNS $97.51
  • TMDX $160.80
  • Average True Range (ATR)
  • CNS 2.09
  • TMDX 7.88
  • MACD
  • CNS -0.57
  • TMDX -1.47
  • Stochastic Oscillator
  • CNS 46.58
  • TMDX 3.90

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for close to two thirds of its $79.3 billion in managed assets at the end of January 2024. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 42% (27%) of its managed assets (base management fees) from institutional clients, 45% (52%) from open-end funds, and 13% (21%) from closed-end funds.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: